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Abstract
This study aimed to further investigate light induced cell death in the rat bladder cancer
cell line AY-27 after incubation with hexylaminolevulinic acid; a treatment known as
photodynamic therapy (PDT). Flow cytometry and confocal microscopy was used to
examine the modes of cell death after treatment. Results from flow cytometry one hour
after light delivery was used to establish dose-response curves for viable, apoptotic and
necrotic cells. These curves indicate that necrosis is the dominant mode of cell death in
our study.
The LD50 dose, found from the survival curve, was used in studies of fractionated and
split light delivery. No altered effect was detected between treatment with fractionated
and continuous light delivery. The survival in split-dose experiments seemed to depend
on conditions before irradiation, but they otherwise gave the same amount of cell death
as fractionated or continuous light delivery. These results were confirmed both by flow
cytometry and by measurements of mitochondrial activity, as found by the MTT assay.
Sammendrag
Dette arbeidet hadde som m˚alsetting a˚ bidra til en større forst˚aelse av lysindusert
celledød i kreftcellelinjen AY-27 etter inkubasjon med hexylaminolevulinsyre; ogs˚a kalt
fotodynamisk terapi (PDT). Flowcytometri og konfokalmikroskopi ble brukt til a˚ kart-
legge mekanismer av celledød etter slik behandling, og data fra flowcytometri e´n time
etter belysning ble brukt til a˚ etablere dose-respons-kurver for viable, apoptotiske og
nekrotiske celler. Resultatene indikerer at celledød ved nekrose dominerer i denne stu-
dien.
LD50-dosen, funnet fra overlevelseskurven, ble brukt i studier av fraksjonert og split-
tet lysbehandling. Det ble ikke funnet noen endret effekt mellom fraksjonert og kon-
tinuerlig lysbehandling. Overlevelsen etter belysning i to like intervaller avbrutt av en
mørkeperiode p˚a fem minutter ser ut til a˚ avhenge av betingelser før belysning, men
ser ellers ut til a˚ gi samme overlevelse som fraksjonert og kontinuerlig belysning. Disse
resultatene ble bekreftet b˚ade ved bruk av flowcytometri og m˚aling av mitokondriell
aktivitet, funnet ved hjelp av MTT-metoden.
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Chapter1
An introduction to PDT and its
applications
1.1 Photodynamic therapy
Photodynamic therapy (PDT) as we know it today has only been developed in the last
century, but light has been used for therapeutic purposes for more than three thou-
sand years. Examples have been found both in ancient Egyptian, Indian and Chinese
civilizations, where light was used to treat diseases such as psoriasis, rickets and skin
cancer [1].
At present, PDT is mostly used in connection with different types of cancer (as seen
in Table 1.1), but can also be used with bacteria. In the latter case PDT could be an
alternative to antibiotic treatment and thus be advantageous when antibiotic resistant
bacteria strains develop. Among possible targets of antimicrobial PDT are acne vulgaris,
periodontal diseases and infected wounds [2, 3].
Photodynamic therapy utilizes an interaction between light and molecular oxygen
in cells or tissue, mediated by a chemical substance called a photosensitizer. These
three components are all needed to get a photodynamic effect. The mode of action
is illustrated in Figure 1.1. The photosensitizer can absorb a photon leading to the
excitation of one of its electrons. Reactive oxygen species (ROS) are formed when
the photosensitizer deexcites in a reaction with oxygen. These ROS can interact with
neighbouring molecules, such as lipids and proteins, and by this cause cell injury.
PDT has several advantages over traditional cancer treatment modalities such as
surgery, ionizing radiation and chemotherapy. It is minimally invasive, has low muta-
genic potential, low systemic toxicity and is selective of cancerous over normal tissue,
due to the preferential accumulation of the photosensitizer in tumor tissue and light
exposure only to the cancerous area [2–4].
As can be seen in Table 1.1, the combination of a photosensitizer and light is also
used in cancer diagnosis; fluorescence diagnosis (FD) or photodynamic diagnosis (PDD),
where fluorescence from excited photosensitizers is used to detect cancer tissue. There
is also much research focusing on photochemical internalization (PCI), a method for
cytosolic delivery of drugs that are trapped in endosomes and lysosomes. In PCI, the
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Figure 1.1: A simple illustration of the principle of photodynamic treatment. Light is
absorbed by the photosensitizer. If the photosensitizer deexcites during a reaction with
molecular oxygen, reactive oxygen species are generated. The ROS can induce lethal or
sublethal damages to a cell by oxidatively damaging lipids or proteins in the cell.
photosensitizer will first adsorbe to the plasma membrane before it is endocytosed into
the membranes of the endocytic vesicles. The drugs trapped inside will enter the cytosol
when the membranes of the endosomes or lysosomes are ruptured following illumination
with an appropriate light source [3].
Table 1.1: Approved photosensitizers for the use in PDT and FD. Adapted from [2, 3]
Trade name Abbreviation Producer Indication
Photofrin HpD Axcan Pharma Barret’s Oesophagus,
Cervical dysplasia,
Cervical cancer,
Lung cancer,
Oesophageal cancer,
Gastric cancer,
Bladder cancer
Visudyne BPD Novartis Age-related macular degeneration
Foscan m-THPC Biolitec Pharma Head and neck cancer
Levulan ALA DUSA Pharmaceuticals Actinic keratosis,
BCC
Metvix MAL Photocure ASA Actinic keratosis,
BCC
Hexvix HAL Photocure ASA FD of bladder cancer
1.2 Bladder cancer 3
1.2 Bladder cancer
According to Parkin et al. [5], urinary bladder cancer causes 130 000 deaths every
year worldwide. 90 percent of these deaths are caused by transitional cell carcinomas
(TCC)1 [6]. Smoking is the most important risk factor for bladder cancer, probably due
to the high content of carcinogenic arylamides in cigarette smoke [6, 7].
As bladder cancer is the fourth most common tumor among males in USA and
the ninth most common cancer worldwide [6], an additional or alternative treatment
modality to surgery, endoscopic resection, chemotherapy and immunotherapy is most
welcome.
Photodynamic therapy could be one such alternative if treatment protocols are op-
timized. Superficial urinary bladder cancer is suited for PDT, because the bladder can
easily be illuminated using optical fibers, it is more translucent than other human tis-
sues [8] and the photosensitizer can be delivered either intravenously or intravesically [7],
which motivates further research on PDT using urinary bladder cancer cells.
The experiments in this project are performed on rat bladder transitional cell car-
cinoma cells (AY-27). Results can with relative ease be further investigated in vivo,
as there are groups at NTNU performing studies where the AY-27 cell line is used to
induce TCC in rats, e.g. the work of Larsen et al. [7].
1.3 Purpose of study
1. Study the modes of cell death in the cancer cell line AY-27 after treatment with
the photosensitizer hexyl-aminolevulinic acid (HAL) and red light.
2. Compare flow cytometry and confocal microscopy for quantitative measurements
of cell death after red light HAL-PDT.
3. Study effects of fractionating the light delivery in red light HAL-PDT.
1Transitional cells form the lining of the bladder, the transitional epithelium

Chapter2
Background
2.1 Photophysical mechanisms in PDT
A photon-excited photosensitizer molecule has several ways of returning to its ground
state. These processes can be visualized using a Jablonski diagram as shown in Fig-
ure 2.1. Radiative processes are represented by straight arrows, whereas nonradiative
processes are represented by dashed arrows.
The different possible transitions between molecular energy states have different
transition probabilities per unit time, and are characterized by transition rate constants.
The lifetimes of the different energy states are defined using these constants. Taking
fluorescence as an example, the fluorescent lifetime τf equals 1/kf , where kf is the
probability per unit time for the molecule to deexcite through fluorescence.
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Figure 2.1: A Jablonski diagram visualizing transitions between energy states in a
molecule. The processes shown are absorption (A), fluorescence (F), phosphorescence
(P), non-phosphorescence (NP), intersystem crossing (ISC), internal conversion (IC),
vibrational relaxation (VR) and energy exchange between two triplet state molecules.
Other processes can also occur.
Absorption (A): Photons of different frequencies with energy hν can be absorbed
when the molecule is in its ground state. The photons are selectively absorbed
depending on the energy levels available to the molecule.
Internal conversion (IC): A non-radiative transition between electronic states of the
same spin multiplicity. This is the main transitional mechanism between S2 and S1
and the lifetime of the upper energy level is short, typically of magnitude 10−14s.
Vibrational relaxation (VR): Excess vibrational energy is dissipated into heat, leav-
ing the molecule in the lowest vibrational level within the same spin state.
Fluorescence (F): Emission of light following a transition from a singlet excited state
to a singlet ground state. This is a “spin allowed” transition, thus having a short
lifetime, of order 10−9 s.
Intersystem crossing (ISC): A transition between states of different spin multiplic-
ity, a socalled “spin-forbidden” transition, but promoted by spin-orbit coupling.
In porphyrins the kisc is quite large, about 70 % of the excited molecules will enter
a triplet state. The presence of molecular oxygen will increase this number of
triplet state molecules [9].
Phosphorescence (P): Emission of light following a transition from a triplet excited
state to a singlet ground state, or from a singlet excited state to a triplet ground
state. This is also a “spin-forbidden” transition, and the lifetime of the triplet
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state will be longer than the fluorescence lifetime, up to seconds (typically 10−3 s
- 1 s). This increases the probability that the excited molecule will interact with
other molecules by transfer of energy [9, 10].
A molecule can have several possible electron configurations, giving different total
energies. In the ground state, the electrons will occupy the molecular orbitals giving the
lowest energy for the molecule. The ground state of most molecules also have paired
electrons [9] giving a total electron spin S = 0 and a spin multiplicity of 2S+1 = 1. These
molecules are said to be in a singlet state, commonly referred to as S0, S1, S2,. . . with
increasing energy. For a molecule having an S0 ground state, the excitation of an
electron from a paired electron pair can produce a state where the two electrons still
have opposite spins, for instance S1, or a state where the two electrons are unpaired;
they have the same spin direction. In the latter case the molecule’s total spin equals
one, giving a spin multiplicity of three. The molecule is now said to be in a triplet state,
referred to as T0, T1, T2,. . .
One exception from the usual molecular ground state of S0 occurs in O2. The
common form of this molecule has a triplet ground state, 3O2, which has been shown
to react strongly with a photosensitizer (e.g. protoporphyrin IX) in its triplet form [11]
— an interaction giving rise to singlet oxygen and the return of the photosensitizer to
its ground state. This mechanism is demonstrated in Figure 2.1, where the excitation
of 3O2 into singlet oxygen is depicted as a consequence of the simultaneous deexcitation
of a sensitizer’s triplet state.
2.2 Wavelength dependence in PDT
The light used to activate the photosensitizer must be able to penetrate tissue to some
amount if it is to reach not only superficial cells. The penetration depth increases with
increasing wavelength, and there is some variability with tissue type, as can be seen in
Table 2.1 [8, 12]. It is therefore important that the photosensitizer absorbs light with
a relatively long wavelength, but not too long, as we need enough energy to produce
singlet oxygen (∆E = 94 kJ/mol [13] (= 5.9 eV/mol)). The wavelenghts between
600-850 nm can penetrate skin to some amount, and still be able to provide enough
energy to excite oxygen from its triplet to its singlet state [13–15]. This means that the
photosensitizer should absorb light within this interval to be relevant for use in cases
where it is necessary for the light to penetrate skin/tissue. The absorption spectrum for
PpIX in Figure 2.4 shows that it has an absorption peak at 635 nm as mentioned before,
but it also shows that the absorption is many times less efficient than the absorption at
405 nm in the blue region1.
2.3 Production of reactive oxygen species
Generation of reactive oxygen species may occur by a large number of physiological and
nonphysiological processes, including their generation as by-products of normal cellular
1Both spectra are measured by the author and fellow student Magnus Berg Johnsen in the course
TFY4 Optical Spectroscopy.
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Table 2.1: Typical optical penetration depths, δ, in human tissue (left). Specific
(measured) optical penetration depths in human tissues (right). δ refers to the depth
at which the intensity of the light is 37% of its original value.
Wavelengths [nm] δ [mm]
400 - 450 0.1 - 0.3
450 - 500 0.3 - 0.5
500 - 550 0.5 - 0.6
550 - 600 0.6 - 2
600 - 750 2 - 3
750 - 1200 3 - 5
Human tissue type δ [mm] at 633 nm
Brain 0.8
Liver 0.9
Lung tumor 1.6
Kidney 2.5
Malignant prostate 2.8
Bladder TCC 4.0
metabolism, primarily in the mitochondria. Normally the oxidative stress in cells is
balanced by the presence of scavengers, preventing the damage coming from ROS from
exceeding toxic levels.
On the other hand, when the cells are exposed to PDT treatment, the ROS level in
the cells exceed the threshold level, and the amount of damage can lead to cell death,
both apoptotic and necrotic [16].
When the photosensitizer (PS) has been excited from the ground state to the first
excited singlet state, an electron can undergo spin inversion and populate the first excited
triplet state at a lower energy. A triplet molecule does not easily react with a singlet
molecule, but if meeting another triplet molecule the magnetic fields created by the
unpaired electrons can interact. The two molecules then exchange energy and become
singlet molecules [10]. This is the origin of a type II photoreaction, one of the two
reactions producing reactive oxygen species in photodynamic therapy.
Type I photochemical reaction: In this process free radicals (ex. OH•), peroxides
(ex H2O2) and superoxides (O2−) are generated by electron or hydrogen transfer
reactions from the PS to water or biomolecules, producing a cytotoxic result. The
sensitizer reacts in this process directly with cell components and is chemically
altered.
Type II photochemical reaction: The PS may also undergo an energy transfer with
3O2, leading to deexcitation of the PS and excitation of the oxygen molecule to
1O2, a very reactive form of oxygen which can oxidatively damage biomolecules.
In this process, the sensitizer acts merely as a mediator.
In a type I photoreaction the photosensitizer can return to its ground state S0 from
another singlet state, while in a type II reaction the transition is from the T1 to the S0
state. Also, in the latter reaction the photosensitizer is not modified, but returns to its
ground state without chemical alterations. In this way the process of energy transfer
from the photosensitizer to oxygen can be repeated many times. It is generally accepted
that the type II mechanism dominates in PDT, but both type I and type II reactions
occur simultaneously. The ratio between the probabilities for the processes to occur
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depends on the type of sensitizer used, the concentrations of substrate and oxygen, as
well as the binding affinity of the sensitizer for the substrate [1, 15].
The generated singlet oxygen has a very limited lifetime(≤50 ns [17]) and diffusion
length in biological tissue (≤20 nm [15, 16]), meaning that the cellular targets are those
in the immediate vicinity of the singlet oxygen production site. 1O2 can react with a
large variety of molecules, such as proteins, nuclear acids and lipids.
Singlet oxygen can also react with the PS, causing photobleaching by oxidation of
the PS and thereby chemical degradation. If the PS is degraded it cannot contribute
to further excitation of oxygen. During illumination, the amount of PS will therefore
decrease, which could lower the efficiency of the photodynamic treatment. This may
be one reason to try fractionated PDT, thus allowing the concentration of PpIX and
oxygen to rise between consequent illuminations.
2.4 Mechanisms of cell death
Destruction of cells and tissue after PDT has been suggested to follow three principal
mechanisms; cellular targeting, vascular damage or immunological response. In this
project we are mostly interested in the cellular targeting — how dose, localization of
the photosensitizer and the therapeutic conditions (such as the light delivery) influence
the response of the cell. But in vivo these responses may be modified by the other
two mechanisms. Vascular injuries induced by PDT can lead to tumor destruction by
hypoxia and nutrient deprivation, and an inflammatory response to treatment could
contribute to tumor destruction [9].
2.4.1 Terminology
It is common to distinguish between two types of cell death; apoptotic and necrotic.
Apoptotic cell death is referred to as an active process following distinct steps, while
necrotic cell death is described as passive, catabolic and degenerative — generally a
response to gross injuries. Necrosis is often triggered by the same insults which at a
lower intensity would cause apoptosis. It has been speculated that having two modes
of cell death separated by a threshold damage may be a way to alert the organism of
the extent of the damage and that this defines whether a repair response is required to
maintain organismal integrity [18].
Some argue that one should, at least, include a third term when discussing cell death,
oncosis, and reserve necrosis for changes secondary to cell death by any mechanism after
membrane disruption [19–21]. Oncosis was proposed by Majno and Joris (1995) [19] to
define the early stage of primary necrosis during which the cells swell. Other character-
istics are swelling of organelles and increased membrane permeability. This is depicted
in Figure 2.2.
Apoptosis is favoured over necrosis by clinicians as the risk of inflammation is lower
and because cell death by apoptosis could have a multiplicative effect, improving the
efficacy of the treatment. Thus, quantifying the apoptotic and necrotic fractions after
PDT in different tumor cell lines is an important part of optimizing treatment protocol.
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Apoptotic death
Apoptosis is a normal part of development and also a normal part of maintenance and
defense of the adult human body. Actually, in our bodies, which consist of nearly 1014
cells, it is estimated that 1011 cells are eliminated each day through apoptosis [22].
Apoptosis is characterised by morphological and biochemical changes, followed by
engulfment of cellular remains by phagocytosis [13]. The cell commits suicide in response
to physiological signals and intracellular damage.
Two major apoptotic pathways have been characterized: the death receptor-mediated
pathway and the mitochondria-mediated pathway. Both pathways lead to the activation
of different caspases2, which will change the cell’s normal behaviour and lead to apop-
totic death. In the first pathway, cell surface receptors from the tumor necrosis factor
gene family are stimulated, leading to activation of caspase-8. In the second pathway,
disruption of mitochondrial function, causing the release of cytochrome C to the cytosol,
will induce processes leading to the activation of caspase-9 [23, 24].
In early stages of apoptotis the cell shrinks. Gradually the mitochondrial structure
is changed and the chromatin is condensed followed by nuclear disintegration and forma-
tion of apoptotic bodies; the cell disintegrates into several vesicles. The fragments can
then be engulfed by macrophages or other neighbouring cells. Other changes include
loss of the mitochondrial transmembrane potential, activation of caspases and DNA
fragmentation [22].
A key event is the translocation of one of the phospholipids situated in the plasma
membrane, namely phosphatidylserine. Normally this phospholipide faces the inside of
the cell, but in the early stages of apoptosis it is translocated to the opposite layer of
the plasma membrane, facing the extracellular space. This is believed to be an “eat me”
signal recognizable to other cells. The apoptotic fragments will then be phagocytized
by other cells or macrophages [25].
Necrotic death
Necrosis is believed to be a less ordered form of cell death following events like infec-
tion, physical injury, ischemia, or excessive accumulation of ROS. The early stages of
necrosis are characterized by swelling followed by rupture of the plasma membrane and
subsequent release of cytoplasmic constituents. This may also be harmful to neighbour-
ing cells, and necrosis often triggers an inflammatory response when arising in living
organisms [18, 22].
2.4.2 How does ROS-generated injuries lead to cell death?
The cell’s main membrane components are lipids and proteins, and the cell’s functional-
ity is based on enzymes and proteins behaving in a correct manner. As reactive oxygen
species can modify both lipids and proteins, they represent a threat to the cell when
they appear in large amounts.
Proteins and lipids can suffer injuries from ROS-attacks on double bonds in polyun-
saturated fatty acids, amino acid residues with sulfur or proteins with sulfhydral links.
2Caspases: Cysteine aspartic acid proteases.
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Figure 2.2: An illustration of how both apoptosis and oncosis can lead to a final stage
of necrosis. In cell culture, the apoptotic bodies are not engulfed by macrophages and
will enter apoptotic necrosis with membrane rupture [19].
Modifications of amino acids can change functions of proteins such as enzymatic activity,
which unrepaired can lead to dysfunction and cell death.
Lipid attacks can lead to necrosis through loss of membrane integrity of both the
plasma membrane and internal membranes such as the lysosomal membrane. Necrosis
can also follow an intracellular leak of proteases from the lysosomes or an uncontrolled
influx of extracellular Ca2+ [18].
Apoptosis is initiated by biochemical signals. Many of these converge in the mito-
chondria activating the mitochondrial-mediated pathway. The intermembrane space of
these organelles contains several proteins which can initiate the apoptotic pathway when
released through pores in the inner or outer mitochondrial membrane. This process is
again controlled by other proteins [23]. It is proposed that PDT can lead to apoptosis
by direct induction of mitochondrial pore opening [23], and it has been found that apop-
tosis also follows oxidative stress imposed on endoplasmic reticulum (ER), contributing
to the cytotoxic effect of ALA-PDT [26].
Oxidative damages to proteins, lipids or DNA may all have a toxic effect on cells.
However, proteins are often catalysts rather than stoichiometric mediators, and dam-
aging one protein would give an effect greater than a stoichiometric one [27]. Recent
studies also show that the oxidation of proteins could be selective [28–30] and may play
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a role in the signaling events which lead to apoptosis or necrosis in cells.
2.5 PDT based on aminolevulinic acid or its esters
A crucial step in PDT is the production of singlet oxygen, commonly written as 1O2,
or other reactive oxygen species. The photosensitizer acts as a mediator between the
incoming light and the potential ROS. Singlet oxygen seems to be accepted as the
most important reactive oxygen species to produce photodynamical injury in biological
systems [4, 15], but the other ROS are also capable of inducing cell death.
To which extent ROS are formed, and where, depends on the choice of photosensi-
tizer. In this project HAL (hexyl-ALA) induced protoporphyrin IX (PpIX) was used.
The history of ALA-PDT started in 1987, when Malik and Lugaci used ALA induced
PpIX with light to inactivate cells in vitro, and Peng et al. at the same time performed
in vivo experiments. It is now a widely practised form of PDT [2], as is evident from
the list of currently opproved clinical photosensitizers, shown in Table 1.1.
2.5.1 The photosensitizer
PpIX is an intermediate in the heme3 biosynthesis which takes place in all nucleated
cells. It can be induced by the heme precursor 5-aminolevulinic acid (5-ALA) or one
of its ester derivatives. Heme is not a photosensitizer in itself, because of the centrally
inserted paramagnetic Fe2+ ion, which causes a significant reduction in excited state
lifetimes [13]. Neither is 5-ALA or its esther derivatives. (See Figure 2.3.)
PpIX is a member of a class of molecules called macrocycles, a family containing
many porphyrins. These are highly conjugated molecules that have a large pi-electron-
rich fused ring with considerable delocalization of the pi-electrons4. Such molecules
exhibit several pi-pi∗ transitions, because of the prensence of many pi and pi∗ molecular
orbitals. Porphyrins in general absorb most efficiently at approximatly 400 nm (the
Soret band), but exhibit a series of weaker pi-pi∗ transitions in the 450-650 nm interval,
called Q-bands [9]. While the Soret band arises from a strong electronic transition
from the ground state to the second excited singlet state (S0 → S2), the Q-band is a
result of a weak transition to the first excited singlet state (S0 → S1) [13]. Different
pi-pi∗ transition possibilities give rise to the specific absorption spectra of each porphyrin
and are influenced by the surroundings. PpIX has a pi-pi∗ transition corresponding to
absorption of light with a wavelength of 635 nm (in ethanol) which is suitable for PDT.
The absorption spectrum for PpIX is shown in Figure 2.4. PpIX will, as shown in the
same figure, also exhibit fluorescence, which can be used for evaluating its intracellular
localization for instance by using a confocal laser microscope.
3Heme is a functional (conjugated) group of e.g. hemoglobin, which binds and releases oxygen [9],
but also several other proteins carry this group.
4pi-electrons occupy molecular orbials called pi-orbitals, binding orbitals in molecules. pi∗-orbitals are
anti-binding molecular orbitals, with a higher energy than pi-orbitals.
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Figure 2.3: Simplified heme biosynthesis. Adapted from [13]
2.5.2 Endogenous production of PpIX
Heme is synthesised in all energy producing cells in the body, and PpIX is, as mentioned
before, the immediate precursor of heme (Figure 2.3). As shown in Figure 2.5, cellular
production of PpIX is located both in the mitochondria and in the cytosol. In mammals
and photosyntetic bacteria the precursor 5-ALA is formed from the easily available
compounds glycine and succinyl-CoA [4], a process catalysed by 5-aminolevulinic acid
synthase (ALAS).
ALAS is one of eight enzymes in the heme biosynthetic pathway, and has a main
regulatory function, which also include inhibition by heme. This is an example of nega-
tive feedback regulation. The regulation will be bypassed when 5-ALA is introduced in
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Figure 2.4: Absorption spectrum of PpIX in ethanol shown in blue. Fluorescence
emission spectrum of PpIX in ethanol shown in green. Notice that only fluorescence
resulting from a depopulation of the S1 state to different vibrational levels of the S0
state is observed. This is because the dissipation of energy via internal conversion
from the second excited singlet state is an extremely rapid process, so efficient that
fluorescence is never observed from the S2 to the S0 state [31].
excess, leading to an accumulation of PpIX. The accumulation is larger in cancer cells
than in normal cells. The reason for this increased accumulation is not fully understood,
but changes in the activity of enzymes catalyzing the different steps in the synthesis can
be relevant.
One example is the activity of ferrochelatase, which has been shown to have a low-
ered activity in some pre-malignant and malignant tissues. This enzyme is responsible
for the last step in the heme biosynthesis; inserting an iron atom in PpIX. Lowered ac-
tivity of this enzyme could then explain some accumulation of PpIX in cancer cells [32].
Other enzymes catalyzing the production of intermediates have been shown to have
an increased activity in malignant tissues, leading to a more efficient production of
PpIX [33]. The vascularity and pH of cancerous tissue is different from healthy tissue
and can lead to a difference in photosensitizer uptake, which can also be caused by the
poor lymphatic drainage in such tissues [1, 3, 15].
Cellular uptake of the precursor
If PpIX is to be produced from ALA, not only must ALA cross the cell’s plasma mem-
brane but also surrounding tissue. This molecule is hydrophilic, and does not cross cell
membranes (or tissue) easily. There are however many other advantages of using ALA
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Figure 2.5: A schematic depiction of the endogenous production of PpIX in eukaryots.
The production cycle takes place both in the cytosol and in the mitochondria. Numbers
denote different enzymes catalysing the processes. Enzymes mentioned in this text are
number one, ALAS, which is inhibited by heme, and number seven, ferrochelatase, which
catalyses the insertion of Fe2+ into PpIX in the formation of heme.
as a precursor. One is the possibility of monitoring sensitizer levels in situ by means of
fluorescence. Another advantage is the rapid systemic clearance of the photosensitizer
(24-48 h). And of course, ALA is a “bio-compatible” molecule. This is a clear advantage
over other chemically synthesised photosensitizers, which do not exist naturally in cells.
In this project, the lipophilic ester derivative hexyl-ALA (HAL) has been used as a
precursor to ease the cell membrane crossing. The uptake of ALA is an active process,
while HAL crosses the plasma membrane through passive diffusion. In addition, esters
such as HAL has been shown to accumulate faster and induce more porphyrins than
ALA itself (references from [4, 17, 34]). HAL is also approved by the European Union
for photodetection of bladder cancer (Table 1.1), and is therefore a promising compound
for PDT therapy.
HAL is converted by esterases in the cells into ALA, which then is used in the
production of PpIX. The localization pattern of PpIX has been shown to be similar
when using ALA or HAL as a precursor [35].
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2.6 Photosensitizer localization and the effects on cell death
Because of the very limited diffusion length of singlet oxygen in tissue, the localiza-
tion of the photosensitizer is very influential to the induction of cell death. PpIX is a
lipophilic molecule, and it has been shown that endogenously produced PpIX in AY-27
cells treated with HAL localize in membrane structures throughout the entire cell. Thus
the photosensitizer can induce injuries at various sites in the cell, including the cell’s
plasma membrane, the ER, lysosomes or mitochondria [35]. According to Plaetzer et al.,
PDT induced damage to these organelles can all lead to active cell death (apoptosis) [23].
In contrast to ionizing radiation, PDT is not likely to have any significant carcino-
genic effect on surviving tissue. This conclusion is based on the fact that practically
none of the photosensitizers tested for PDT enter the nucleus, and therefore they have
a low potential for producing mutations [36].
As PpIX is formed in the mitochondria of eukaryotic cells, one would expect mito-
chondria to be important targets of ALA-PDT. Mitochondria have indeed been shown
to be initial targets after this treatment [17]. Since targeting of mitochondrial functions
is a mechanism for inducing apoptosis [37], some of the cytotoxicity of PDT could be
associated with triggering the mitochondrial apoptotic pathway. As mentioned earlier,
evidence of apoptosis following the mitochondrial pathway has been found [23, 26].
It has been shown that PDT is effective even in cancer cells resistant to apoptosis [18],
and it is believed that necrosis is the dominant path at least for large PDT doses [36],
while apoptosis is more important at smaller doses. The fact that PDT is effective even
in cells otherwise resistant to apoptosis can imply that necrosis is the more important
pathway, but also that apoptosis is triggered at a late stage after PDT, bypassing the
normal signaling process initiating the mitochondrial apoptotic pathway.
2.7 Fractioning the light delivery
In radiotherapy5, it has been found that fractionation of the radiation dose will produce,
in most cases, better tumor control for a given level of normal-tissue toxicity than a single
large dose [38]. Fractionation exploits the difference between sublethal damage repair
in normal tissue and tumors, and will also allow tumor reoxygenation between doses,
which increases the radiosensitivity of the tumor.
There are similarities beween survival curves obtained by PDT and ionizing radia-
tion, such as a shoulder region for low doses. Repair of sublethal PDT damage has been
documented in some split-dose experiments [39], but it is not known whether or not a
repair differential exists between normal and diseased tissue.
As oxygen is needed to produce a cytotoxic effect in PDT, reoxygenation during dark
intervals could increase the effect of photodynamic treatment if depletion of oxygen is a
problem. The amount of available photosensitizer is also a rate limiting factor in PDT,
and in HAL-PDT the formation of new PpIX molecules from HAL in the tissue/cells
during a short dark period could result in an increased therapeutic effect.
5The treatment of disease with ionizing radiation.
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2.8 Theoretical survival curves — hit theory
Dose response curves obtained in PDT experiments can be interpreted using hit the-
ory, originally developed for survival curves after treatment with ionizing radiation.
Although the model has limitations, parameter values obtained by using this theory
provides information which can be used in comparison of different treatments or treat-
ment regimes.
The model is based on two physical observations and one postulate [40]. Translated
to the case of PDT, they become:
1. Light transfers energy in discrete packages (photons).
2. The interactions (hits) are independent of each other and follow a Poisson distri-
bution.
3. The response under investigation occurs if a specified target has recieved a defined
number of hits.
If the radiation sensitivity is ν, and the dose is D, the Poisson distribution gives the
probability of recieving exactly m hits, as
P (m) =
(νD)m
m!
e−νD.
If the object of interest has n targets, each needing m hits for inactivation, then the
probability of survival S, is
P (S) = 1−
(
1− e−νD
m−1∑
m=0
(νD)m
m!
)n
. (2.1)
A special case of equation (2.1) is the single hit, multi target model, which has
been used to describe survival curves following photodynamic treatment (e.g. [41]). In
this case, each of the n targets need exactly one hit for the object to be inactivated.
This model seems appropriate if the object to be inactivated is a cell, containing many
potential protein and lipid targets. If the number of inactivated biomolecules is large
enough, the cell wil not be able to maintain its normal functions, and it will die.
If the radiation sensitivity is given by ν = 1/D0, the expression for the survival in
the single hit, multi target model becomes
P (S) = 1− (1− e−D/D0)n. (2.2)

Chapter3
Experimental methods
3.1 Motivation for this chapter
To perform your experiment correctly, it is important to understand the techniques you
are using. Knowing the limitations of the instruments or reagents used is important
to be able to process and discuss the results obtained. A chapter briefly covering each
method used in the project is therefore included, but the methods are described in
further detail in chapters 4 (p. 25) and 5 (p. 49).
3.2 The MTT assay — measuring mitochondrial activity
If you are not concerned about the type of cell death achieved after PDT, survival of
the treated cells can be measured by the MTT assay. One alternative to this method is
colony counting, but the MTT assay is the method commonly used with PDT on AY-27
cells, and is quite easy to perform. It is common to do the analysis 24 h after treatment,
and e.g. the LD50 dose can be determined from the information obtained. This dose is
often of interest when planning other experiments where for instance the total protein
content after treatment is important for further studies. In this study it was used as an
alternative method in measuring the effect of fractionated therapy.
Yellow MTT, a tetrazolium salt, is reduced to purple formazan in the mitochondria of
living cells (Figure 3.1). These reductions take place only when mitochondrial reductase
enzymes are active, that is when the mitochondria is not dysfunctional.
The reduction product, formazan, is water insoluble. Isopropanol can be used to
dissolve the purple formazan precipitate into a colored solution, and the absorption can
be measured with a spectrophotometer. The absorption peak will depend on the solvent
used. When isopropanol is used, the absorption is measured at λ = 595 nm.
When the amount of formazan produced by cells having recieved PDT is compared
with the amount of formazan produced by untreated cells, the effectiveness of the PDT
treatment can be deduced. There will be a linear relationship between the number of
living cells (cells with intact mitochondrial reductases) and the absorbance of the colored
solution [42]. This way the absorbance can be used to measure the relative amount of
living cells after PDT treatment.
19
20 Chapter 3 Experimental methods
Figure 3.1: Illustration of the reduction of MTT to formazan by the enzyme mito-
chondrial reductase.
3.3 Distinguishing between apoptotic and necrotic cells
It is of great interest to know how and when the cells die after treatment. One way
of sorting the cells in the categories viable, apoptotic and necrotic are by fluorochrome
staining followed by flow cytometry or confocal laser scanning microscopy (CLSM).
3.3.1 Fluorochrome tagging by Annexin V Fluos and Propidium Io-
dide
Two dyes (fluorochromes) are commonly used to differentiate between apoptotic and
necrotic cells in a population, Annexin V Fluos (Ax) and Propidium Iodide (PI). The
labelling and detection of apoptotic cells is based on changes in the outer leaflet of
the plasma membrane. In viable cells, the phospholipide Phosphatidyl serine (PS) is
directed towards the cytoplasm. However, in apoptotic cells, PS appears on the outer
leaflet towards the extracellular environment, where it can bind to fluorescent Annexin
V-conjugates [23].
Cells with highly permeable or broken plasma membranes, necrotic cells, will display
fluorescence from PI, as PI binds to double stranded nuclear acids; DNA or RNA.
Necrotic cells will also display fluorescence from Ax, as it can bind to PS in the inner
leaflet of the plasma membrane.
Early apoptotic cells are impermeable to PI, but will display PS on the outer leaflet
early in apoptosis. This event preceedes cell membrane permeabilization, cell shrinkage
and nuclear condensation, and is used as a marker of early apoptosis [43].
Combined, Ax and PI is used to separate the cell population in three; viable, apop-
totic and necrotic cells. The fluorescence can be detected e.g. in a flow cytometer or
a confocal microscope. The absorption and emission spectra of PI and Ax are given in
Figure 3.2a.
3.3.2 Fluorochrome tagging by YO-PRO-1 and Propidium Iodide
As mentioned earlier, the permeability of the cell membrane changes during apoptosis.
Assays for apoptosis using YO-PRO-11 and PI use these permeability changes to dif-
ferentiate between viable, apoptotic and necrotic cells. Viable cells are not appreciably
1See Abbreviations ,page ix.
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Figure 3.2: The absorption (dashed line) and fluorescence (solid line) spectrum of the
fluorochromes used in this study. All fluorochromes were excited at 488 nm. (Source of
data: Invitrogen)
stained by either YO-PRO-1 or PI, and YO-PRO-1 will enter the cell at an earlier stage
in apoptosis than PI. Necrotic cells are permeable to both dyes.
The absorption and emission spectra of PI and YO-PRO-1 are given in Figure 3.2b.
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3.4 Flow cytometry
Cells which are to undergo flow cytometry must be in suspension, as measurements are
done in a single cell manner. To obtain quantitative measurements, cellular molecules
must be labelled by fluorescent molecules in a stoichiometric manner. These fluo-
rochromes are excited by a light pulse from a laser source, and the detected fluorescence
is ideally proportional to the property in question. In this study, an argon laser line at
488 nm was used to excite the fluorochromes. Correct measurements are based on equal
illumination of each cell. This is achieved through hydrodynamic focusing of the cell
suspension and an elliptical illumination field.
In hydrodynamic focusing the cell suspension is enclosed in a sheath fluid producing
a single particle flow. A schematic of the flow cell is shown in Figure 3.3. The velocity
of the sheath fluid defines the particle velocity independently of individual size, which
ensures equal illumination time for all particles.
Beam shaping optics is used in the laser beam path to make an elliptical focus spot
in the laminar flow region of the flow cell of approximately 60 µm perpendicular to the
fluid flow and 20 µm in the direction of the flow. The advantage of using an elliptical
over a circular focus spot is that the elliptical focus provides a wider illumination field
across the width of the flow so that the optical response does not fluctuate if cells stray
from the center of the beam. The short dimension parallel to the flow ensures that only
one cell hits the focal volume at one time [9, 44].
Fluorescent light is detected by several photomultiplier tubes (PMTs) according to
wavelength. In addition to fluorescence, scattered light is also detected. Low angle
scattering resulting from diffraction of the beam is detected by a photo diode and give
information about cell size. High angle scattering resulting from reflection and refraction
on cell structures is detected by another PMT and give information about structure or
granularity of the cells [9].
Core inlet Sheath inlet
Sheath
constricts
core
Slug flow
Laminar flow
Figure 3.3: A schematic depiction of single cell flow obtained by hydrodynamic focusing
in the flow cell.
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3.5 Confocal laser scanning microscopy
In a conventional wide-field microscope, thick specimens will produce an image that rep-
resents the sum of sharp image details from the in-focus region, combined with blurred
images from all the out-of-focus regions. This problem is overcome in confocal mi-
croscopy by introducing a variable pinhole in the path of the image forming beam (e.g.
fluorescence) as shown in Figure 3.4. The pinhole rejects the out of focus contribution
because light from other object planes than the focal plane do not converge at the pin-
hole and is blocked. In addition the pinhole blocks much of the stray light in the optical
system.
To build a 2D image the focused laser beam is scanned in a raster pattern over points
in an xy-plane of the specimen. A 3D image can be reconstructed from such optical
sections by scanning the specimen with different heights of the focal plane [9, 44].
In this study, an Argon laser line at 488 nm was used to excite the fluorochromes.
The fluorescent light was detected in the range of 500 nm - 550 nm (Ax), and 650 nm -
720 nm (PI), which excludes the excitation beam.
Objective lens
Laser
point
source
Detector
Aperture
Beam splitter
Focal plane
Specimen
Figure 3.4: Schematic figure showing the principle of confocal imaging, where an
aperture (a pinhole) is used to block light not originating from the focal plane.

Chapter4
Materials and methods
4.1 Culturing the cell line AY-27
AY-27 cells originate from rat bladder transitional cell carcinoma (TCC), and grow in
a monolayer [45]. An ideal number of 2 · 106 cells were seeded in 75 cm2 cultivation
flasks twice a week in 15 ml cultivation medium. The cultivation medium consisted of
RPMI-1640 supplemented with fetal bovine serum (FBS) and L-glutamine. 50 ml FBS
and 1.7 ml L-glutamine was added to 500 ml RPMI-1640. The cells were incubated in a
Binder incubator at a temperature of 37 ◦Cwith a humified atmosphere containing 5%
CO2.
Cultivation medium, PBS, FBS, accutase and MTT were all purchased from Sigma-
Aldrich, while Petri dishes and well plates were obtained from Nunc. HAL was kindly
provided by Photocure ASA (Oslo).
4.2 The light source
The light source used in the experiments was an Aktilite lamp, model CL-128 from
Photocure ASA. The lamp was situated in a room holding a temperature of 37◦C. To
lower the irradiance and to make the light more homogenous, a housing with a diffuser
plate (white glass) on top was used. In this setup, the irradiance was measured to be
on average 20 mW/cm2 on top of the diffuser.
The spectrum of the lamp had previously been measured, showing a peak at 631 nm,
which was used in calculations regarding the dose recieved by the cells, see Figure 4.1.
4.2.1 Light absorption measurements
To quantify the irradiance of the light hitting the petri dishes or wells and the dose
given to the cells during irradiation, irradiance measurements were performed on the
light source using a PAR1 detector (LI-COR Quantum Detector, type LI-190SA).
Inspired by the in vivo experiments performed by Larsen et.al [7], it was decided to
use an irradiance of 20 mW/cm2 in this study.
1Photosynthetically Active Radiation
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Figure 4.1: Spectrum of the red light source used in the PDT experiments [12].
4.3 Pilot studies
One of the objectives of this study was to compare flow cytometry techniques to confocal
microscopy techniques when quantifying apoptosis and necrosis after PDT experiments.
In the pilot studies, we tried to make protocols suitable for comparison of results between
the two modes of measurement, which hopefully would lead to more reliable results.
Protocols tested in the pilot studies are included in the following pages.
4.3.1 Use of Annexin V Fluos and Propidium Iodide
A common way of detecting apoptosis and necrosis is using the nuclear dye Propidium
Iodide (PI) and Annexin V Fluos (Annexin, Ax). The selectivity is based on the flipping
of phosphatidylserine in the plasma membrane of the cell early in apoptosis. As viable
cells are impermeable to PI and Ax, necrotic cells are permeable to both, and apoptotic
cells will bind Ax on the outside of their plasma membrane, this method separates the
population in three.
Annexin binds to PS in a calcium dependent manner, and an incubation buffer was
used to obtain the correct concentrations of ions. Contents of the Hepes buffer (pH 7.4)
is given in Table A.2.
In addition to the modes of cell death after HAL-PDT, the effect of using Accutase
in detachment of cells instead of Trypsin/EDTA was to be observed. All results can be
found in the next chapter.
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Obtaining comparable results with flow cytometry and confocal microscopy
As a first attempt, the experimental design as shown in Figure 4.2 was used. This design
gives equal treatment and stress level to all samples before detection in a flow cytometer
or confocal microscope.
Seed cells in Petri dishes (Day 1)
↓
Incubate cells with fresh HAL solution (10 µM, 3.5 h) (Day 3)
↓
Remove HAL, wash cells with PBS, add PBS for irradiation
↓
Irradiate cells
↓
Remove PBS, add growth medium, incubate (37◦C, 5% CO2)
↓
Remove medium, wash with PBS
↓
Detach cells using Accutase
↓
Transfer to tubes, centrifuge (1300 rpm, 3 min)
↓
Remove supernatant, resuspend in fresh Ax/PI solution (10 min)
↓
Add PI solution to increase volume
↓ ↓
Filtrate Transfer to wells
↓ ↓
Do flow cytometry Do confocal microscopy
↓
Compare results
Figure 4.2: Protocol used in pilot studies of the apoptotic and necrotic fraction after
HAL-PDT on AY-27 cells, using Ax and PI as fluorescent markers.
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Optimization of each method of detection
A second option is to optimize the methods for either flow cytometry or confocal mi-
croscopy. The cells will then recieve minimal handling before observation, but the results
from flow cytometry and confocal microscopy observations will differ to some extent,
and may not be compared directly. Samples to undergo flow cytometry are handled as
described in Figure 4.2, while samples to undergo confocal microscopy after treatment
are handled as described in Figure 4.3.
Seed cells in wells (Day 1)
↓
Incubate cells with fresh HAL solution (10 µM, 3.5 h) (Day 2 or Day 3)
↓
Remove HAL, wash cells with PBS, add PBS for irradiation
↓
Irradiate cells
↓
Remove PBS, add growth medium, incubate (37◦C, 5% CO2)
↓
Remove medium, wash with PBS
↓
Add fresh Ax/PI solution, incubate 10 min
↓
(Add PI solution)
↓
Study cells in confocal microscope
Figure 4.3: Protocol used in confocal microscopy studies of AY-27 cells after HAL-PDT
treatment, using Ax and PI as fluorescent markers.
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4.3.2 Use of YO-PRO-1 and Propidium Iodide
As earlier studies have reported some problems with the Ax/PI assay and because
we measured a surprisingly low level of apoptosis in our experiments, we decided to
try a combination of fluorochromes which did not rely on Annexin V binding to phos-
phatidylserine. If the results were drastically different, we would consider other methods
for the detection of apoptosis in the AY-27 cell line.
It was decided to try change in membrane permeability as a marker of apoptosis,
measuring fluorescence by flow cytometry and confocal microscopy with the nuclear
stains YO-PRO-1 and PI. As the cell goes through apoptosis, the permeability of the cell
membranes will change gradually. According to the manufacturer of Vybrant Apoptosis
Assay Kit 4 (Invitrogen), necrotic and apoptotic necrotic cells will be permeable to both
nuclear stains, while early apoptotic cells are only permeable to YO-PRO-1. Viable cells
will not be permeable to either of the fluorochromes.
Seed cells in Petri-dishes (Day 1)
↓
Incubate cells with fresh HAL solution (10 µM, 3.5 h) (Day 3)
↓
Remove HAL, wash cells with PBS, add PBS for irradiation
↓
Irradiate cells
↓
Remove PBS, add growth medium, incubate (37◦C, 5% CO2)
↓
Remove medium, wash with PBS
↓
Detach cells using Accutase
↓
Transfer to tubes, centrifuge (1300 rpm, 3 min)
↓
Proceed work on ice
↓
Resuspend cell pellet in cold PBS (1 ml) containing YO-PRO-1 (1 µl, Invitrogen) and
PI (1 µl, Invitrogen)
↓
Incubate (25 min, on ice)
↓
Filtrate
↓
Do flow cytometry
Figure 4.4: Protocol used in flow cytometry studies of AY-27 cells after HAL-PDT
treatment, using YO-PRO-1 and PI as fluorescent markers. The protocol had some
minor changes, such as no detachment, when the cells were grown in well plates and
examined by confocal microscopy.
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4.4 Protocols used in the remaining studies
As can be seen in Chapter 5, difficulties with the confocal microscopy experiments
made us choose flow cytometry in the remaining studies. Also, as there were no clear
advantages found with the use of the alternative fluorochrome, Annexin V Fluos and
propidium iodide were used to separate necrotic and apoptotic cells, as described in
Figure 4.2. The incubation time post-PDT was either 1 hour or 24 hours.
4.4.1 Preparation of the cells and the photosensitizer
Two days prior to treatment with PDT, the cells were seeded in Petri dishes (r = 3 cm)
at a concentration of 1.5 · 104 cells per ml cultivation medium, for a total of 6 · 105 cells
ideally. On the day of the experiment, a stock solution of 10 mM HAL was made (2.52 mg
HAL/ml pH 6.0 PBS) and sterile filtrated (0.22 µm). Cultivation medium without FBS
was used to make a working solution (10 µM). Cultivation medium without fetal bovine
serum was used because it has been found to influence the intracellular PpIX content,
by extracting PpIX out of the cell.
4.4.2 Photodynamic therapy
The cells were washed in PBS, incubated with HAL (10 µM, 3.5 h) and washed in
PBS again (x2). A minimum of two Petri dishes were used as control samples in the
experiments, not recieving neither HAL nor light. Two Petri dishes recieved only the
photosensitizer to reveal any toxicity and the rest were irradiated from 15 s to 30 min,
depending on the experiment. The cells were irradiated with 2 ml PBS present. After
irradiation, the PBS was removed from the Petri dishes and regular cultivation medium
given. The cells were then incubated for 1 h or 24 h depending on the experiment, before
viability or mode of cell death was examined by flow cytometry, confocal microscopy or
the MTT assay.
Some remarks regarding the flow cytometry experiments
After the post-PDT incubation time, the cells were detached by adding 3.3 ml Accutase
(20 min, 37 ◦C) to the dishes after washing with PBS. Further treatment was performed
as described in Figure 4.2 with the instrumentsettings given in Appendix A.4.
The cells were collected with their supernatants if the post-PDT time was 24 hours,
while they were collected without their supernatants if the post-PDT incubation time
was only 1 hour. Results from pilot studies (data not included) showed that the total
cell count in supernatants 1 hour after PDT was negligible compared to the cell counts
from the detached cells, and that apoptotic cells were not overrepresented compared to
the detached cell population. Thus by not including the supernatants in the 1 h samples,
we did not lose any information. 24 hours after treatment, more cells have detached
as they proceed through apoptotic or necrotic cell death, and the supernatants were
collected before the cells were detached
4.4 Protocols used in the remaining studies 31
Some remarks regarding the confocal microscopy experiments
In the experiments where confocal microscopy was used, incubation, irradiation and
examination of the samples were done in several intervals, to avoid a queue of samples
waiting to be examined. While flow cytometry of one sample is done in 1.5 minutes
(20000 counts, 250 counts/s), focusing and capturing of one image in each of eight wells
(one sample) may take more than five minutes.
The MTT assay
In the studies of fractionated light delivery, also the MTT assay was used to determine
survival after treatment, and the protocol can be seen in Figure 4.5. A stock solution
(5 mg/ml) was made, kept refrigerated (4 ◦C) and protected from light. At the day of
the experiment, a working solution (0.5 mg/ml, 37 ◦C) was made using regular culti-
vation medium. The cells were incubated with the working solution for 1 hour, before
isopropanol (2 ml) was added and the petri dishes placed on a shaker (500 rpm, 30 min).
The colored solution was transferred to tubes and centrifuged (5 min, 1500 rpm). Ab-
sorption measurements of the supernatants were performed immediatly (λ = 300 nm -
700 nm) on a Shimadzu UV-160 1PC spectrophotometer.
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Seed cells in Petri dishes (Day 1)
↓
Incubate cells with fresh HAL-solution (10 µM, 3.5 h) (Day 3)
↓
Remove HAL, wash cells with PBS, add PBS for irradiation
↓
Irradiate cells
↓
Remove PBS, add growth medium
↓
Incubate (1 h or 24 h)
↓
Remove medium, wash with PBS, add fresh MTT-solution (0.5 mg/ml) (Day 4)
↓
Incubate (1 h)
↓
Remove MTT-solution, add isopropanol, put on shaker (30 min)
↓
Add solution to tubes, centrifuge
↓
Transfer supernatant to new tubes
↓
(Dilute with isopropanol)
↓
Measure absorption of solution λ = 595 nm
Figure 4.5: Protocol used for measuring survival of the AY-27 cells after HAL-PDT
using the MTT assay.
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4.5 Fractionated therapy
To study the effect of different forms of light delivery, it was decided to use the dose
giving 50% cell death 1 h post PDT. This dose of 5.4 J/cm2 corresponds to a light
exposure time of 270 s. Inspired by Oberdanner et al. [46] we used (1) fractionated
delivery with 45 s light and 60 s dark periods and (2) continuous light delivery. In
addition we included a (3) split dose experiment with 135 s of light exposure, 300 s in
the dark followed by another 135 s of light exposure.
Survival, apoptosis and necrosis was measured after 1 h and 24 h, both by the MTT
assay and by flow cytometry using the Annexin V/PI method. The experiments are
illustrated schematically in Figure 4.6.
Add dyes FlowDetach
t1
30 min
t2 t3
t4 t5
Light delivery
Fractionated
Continuous
Split-dose
Timeline Flow
Timeline MTT
MTT Isoprop OD595
M
o
d
e
of
li
gh
t
d
el
iv
er
y
Figure 4.6: An overview of the experiments where fractionated and split light delivery
is compared to continuous delivery. The timeline on top describes the experiment when
survival is measured by the MTT assay, while the bottom line describes the experiment
when survival is measured by flow cytometry. The three light delivery regimes shown are
further described in this section. To get comparable results between the two methods,
t1 + t2 + t3 = t4 + t5.

Chapter5
Results
5.1 A summary of the results from the pilot studies
There were many lessons to be learned from these early experiments, and with no previ-
ous experience in flow cytometry or confocal microscopy they provided the opportunity
to learn the techniques. Experiences which influenced the treatment protocol and mea-
surements of apoptosis and necrosis are briefly mentioned here:
Detachment of cells using Accutase: In earlier projects where AY-27 cells were
treated with ALA and red light, cell aggregation after detachment with Trypsin/EDTA
created problems for analysis through flow cytometry. As depicted in Figure 5.1,
cell aggregation is not a problem when detachment is performed using Accutase.
The detachment time for untreated cells at Day 3 was on average 12 minutes if
seeded on Day 1 (0.04 · 106/ cm2) (data not included). Remarkably, the detach-
ment time increased following HAL-PDT, and up to 20 minutes was needed to
detach cells having recieved 5.4 J/cm2.
Light dose: To discuss the type of cell death after treatment with any certainty,
the treatment should give cell death ranging from zero to at least 90 percent.
From Figure 5.2, we see that the cell survival is never under 75 percent, a level
reached after a dose of 2.4 J/cm2. We should therefore include higher doses to get
more informative results. Also, as there were only small differences between the
apoptotic levels one and four hours after HAL-PDT, 1 hour after treatment was
chosen as the time to do measurements.
Detection of apoptosis: From the confocal microscopy images, such as shown in
Figure 5.1, it seems that cells showing blebs characteristic for apoptosis, are fre-
quently not tagged by the fluorochrome Annexin V Fluos, raising questions about
the use of this method with the AY-27 cells. We decided to repeat the experiments
using another assay for apoptosis to check for similar results.
Confocal microscopy studies: If the cells are not grown in wells suited for confocal
microscopy, but need detachment before examination, it is only possible to focus
on the cells that have sedimented to the bottom of the wells. We can not be sure
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Figure 5.1: Confocal microscopy image of AY-27 cells 1 hour after red light HAL-PDT
(3.5 h, 10 µM, 2.4 J/cm2). The cells were handled as described in Figure 4.2, using
Accutase to detach cells from the Petri-dishes before incubation with Ax/PI and loading
in wells for confocal microscopy. The image clearly shows that PI (red fluorescence) is
a nuclear dye, while Ax (green fluorescence) binds to phospholipides in the membrane.
Still, cells having apoptotic morphology does not necessarily show any fluorescence. Cell
aggregation, on the other hand, seems not to be a problem when accutase is used.
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Figure 5.2: (a): Viable, apoptotic and necrotic cells 1 h after HAL-PDT (10 µM, 3.5 h)
as measured by flow cytometry with Ax/PI. (b): Viable, apoptotic and necrotic cells
4 h after HAL-PDT (10 µM, 3.5 h) as measured by flow cytometry with Ax/PI.
if the cells reaching the bottom is representative of the original population, as
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Figure 5.3: (a): Apoptotic and necrotic cells 1 h after HAL-PDT (10 µM, 3.5 h),
counted after confocal microscopy with Ax/PI. (b): Apoptotic and necrotic cells 4 h
after HAL-PDT (10 µM, 3.5 h), counted after confocal microscopy with Ax/PI. Mean
values and standard deviation is drawn at each point based on images from 2x4 wells.
there may be differences in the sedimentation properties of dead and viable cells.
Secondly, cells which have been detached and handled much before inspection,
will be structurally changed relative to cells treated and inspected when grow-
ing in their usual monolayer, which may influence the measurements. Figure 5.3
shows the measured apoptosis and necrosis after HAL-PDT on the AY-27 cells.
The cells were detached with accutase after treatment and incubated with Ax/PI
before inspection by confocal microscopy. The mean values both at one and four
hours after treatment seem to correspond well with the flow cytometry results in
Figure 5.2. However, the uncertainty in each point is large as the countings in
each well never exceeded 100 cells, giving small variations a great influence on the
result.
Several attempts were made using the protocol shown in Figure 4.3, where the
cells are grown in wells two days before HAL-PDT and inspected by confocal
microscopy. Unfortunately, we were not able to get any clear results with this
method, as the cell death varied considerably between wells in the same well
plate. The experiments were performed using several incubation times to avoid a
queue of samples waiting to be analysed. This made the experiments extremely
time consuming, and as the information obtained was of low quality, we did not
continue using the confocal microscope for such quantitative studies. Examples of
the images obtained can be found in Figure 5.4. Numerical data from these studies
are not included, but the standard deviations are in the same range as shown in
Figure 5.3.
Extracting information from the flow cytometer: The flow cytometer measures
fluorescence from both fluorochromes in each passing cell, placing each cell in a 2D
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plot based on the two parameters. This information provides a way to separate
the population in viable, apoptotic and necrotic cells. The separation is done by
the viewer of the data, and is therefore highly subjective. The following figures
show how the populations are separated in this study using MATLAB, where all
data from flow cytometry experiments were post-processed.
Instead of the 2D dotplots provided by the flow cytometer’s software, density plots
are shown. They give a better impression of the number of cells with the same
fluorescent properties than dotplots, as the latter will have “blackouts” in areas
containing many cells. Density plots were made by adding height information to
the 2D (1024x1024) grid where each cell is placed during flow cytometry. Each
grid point recieved counts from cells placed in that position, and the fluorescence
from each cell also influenced the count in each of the eight neighbouring points,
creating density information.
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(a) Untreated cells (b) Only fluorescence (3.6 J/cm2)
(c) Treated cells (1.8 J/cm2) (d) Treated cells (3.6 J/cm2)
(e) Treated cells (1.8 J/cm2) (f) Treated cells (3.6 J/cm2)
Figure 5.4: (a): Shows healthy AY-27 cells, displaying their ability to adhere and use
available space. (b): Fluorescence 1 hour after HAL-PDT using the fluorochromes YO-
PRO-1 (green fluorescence) and PI (red fluorescence), illustrating that both are nuclear
dyes. (c) and (d): Confocal microscopy images 1 hour after HAL-PDT using YO-PRO-1
and PI. (e) and (f): Confocal microscopy images 1 hour after HAL-PDT using Ax (green
fluorescence) and PI.
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Figure 5.5: Results from flow cytometry displayed as density plots showing the results
after 20000 counts for each sample. Fluorescence from Ax and PI are detected for each
cell. Ranging from dark blue to red, density of cells range from lower to higher. The
measurements are performed 1 h after HAL-PDT (10 µM, 3.5 h). Cells in the lower
left quadrant are defined as viable, those in the lower right as apoptotic, while the two
upper quadrants contain necrotic cells.
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Figure 5.6: Results from flow cytometry displayed as density plots showing the results
after 20000 counts for each sample. Fluorescence from YO-PRO-1 and PI are detected
for each cell. Ranging from dark blue to red, density of cells range from lower to higher.
The measurements are performed 1 h after HAL-PDT (10 µM, 3.5 h). As in Figure 5.5,
the lower left region represents viable cells, the lower right region represents apoptotic
cells and the upper region represents necrotic cells.
5.1 A summary of the results from the pilot studies 41
Alternative apoptotic marker:
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Figure 5.7: Viable, apoptotic and necrotic fraction of AY-27 cells 1 h after HAL-PDT
(3.5 h, 10 µM) measured by flow cytometry using YO-PRO-1 and PI.
As Figure 5.7 shows, we did not detect any high apoptotic levels by using the the
alternative fluorochrome either, though we did get a maximum value of 15% at
3.5 J/cm2 which is larger than the values given by the Ax/PI method at any point
(Figure 5.2a). Inspection of Figure 5.7 reveals a dip in survival at 1.8 J/cm2, which
is probably incorrect, as it is not likely that the survival curve has a local minima
here. If these values are disregarded, the results using the two sets of fluorochromes
are quite similar, though the apoptotic level seems slightly higher when using YO-
PRO-1 and PI. Still, because it was even harder to separate the cells in viable,
apoptotic and necrotic fractions (compare Figure 5.5 and Figure 5.6), and since
the Ax/PI method is the most common of the two, it was decided to continue
using the latter fluorochrome pair in the subsequent experiments.
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5.2 Cell death following HAL-PDT with continuous light
delivery
As Figure 5.8 and Figure 5.9 shows, cell death after HAL-PDT on AY-27 cells increases
with increasing light dose. A shoulder region is observed in the survival curve 1 h post-
PDT. The LD50 value 1 h after treatment was found to be 5.4 J/cm2, corresponding to
an irradiation of 4.5 minutes at 20 mW/cm2.
As the dose increases the cells appear increasingly necrotic, while the apoptotic level
is low and constant (about 4 percent) until a dose of 5 J/cm2 is reached. Following a
rapid change, it settles at a new constant level of 10 percent. The necrotic level rises
earlier than the apoptotic level. From a background level of 4 percent in untreated
samples, it reaches 10 percent already after 2 minutes of irradiation, and continues
to rise until 90 percent necrosis is reached after 12 J/cm2 (which equals 10 min of
irradiation). Figure 5.9 gives the same information as Figure 5.8a, but with a linear axis
and error bars. The measurement uncertainty is clearly largest at 6 J/cm2. This is as
could be expected, as the region between 5 and 10 J/cm2 has the most rapid decrease
in survival. Small changes in dose in this region will lead to large changes in survival.
Not only fluorescent light is collected by the flow cytometer. The laser beam used
for excitation of the fluorochromes will be scattered by the passing cells, and this light
is collected at small angles, forming the forward scattering signal often used to give an
impression of cell size. In untreated cells, the size will have a simple gaussian distribu-
tion. In treated samples, the different populations present will give rise to a combined
distribution as they swell or shrink. By averaging the forward scattered signal it is
possible to get an impression of the dominant cell size in the sample. This is shown in
Figure 5.8b. There seems to be an early increase in cell size for low doses, followed by
a rapid decrease to a stable level reduced by a factor 2 compared to untreated samples.
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(a) Viable and dead cells
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Figure 5.8: (a): Semilogarithmic plot showing dell death following HAL-PDT
(10 µM, 3.5 h) on AY-27 cells measured by flow cytometry using Annexin V Fluos
and Propidium Iodide to separate the population in three. Data points represent mean
values from four separate experiments, each with two parallells. (b): The average for-
ward scatter signal as a function of dose in the same experiment as (a).
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Figure 5.9: Fractions of viable (a) and dead (b) AY-27 cells following HAL-PDT
(10 µM, 3.5 h) measured by flow cytometry using Ax and PI to separate the population
in three. Mean values ± standard deviation based on four separate experiments are
given, each with two parallells.
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By using the survival values measured by flow cytometry, originating from doses
ranging from 0 to 12 J/cm2, corrected to give 100 percent viability at D = 0, we can
compare our results to theoretical survival curves derived from hit-theory as given in
equation (2.2, page 17). These curves have two independent variables; the exponential
slope of the survival curve, D0, and the number of targets to be inactivated before a cell
is killed, n. A third parameter, called the quasithreshold value (Dp = D0 ln n), is often
used to describe the shoulder width. The parameter values which seemed to fit our data
best is listed in Table 5.1. The resulting survival curves are plotted in Figure 5.10.
Table 5.1: Survival curve parameters
D0 [J/cm2] n Dp [J/cm2]
2.5 4 3.5
2.5 5 4.0
2.5 6 4.5
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Figure 5.10: Theoretical survival curves from the single hit, multi target model is fitted
to mean values with error bars from flow cytometry experiments as shown in Figure 5.8.
The surviving fraction, S = 1 - (1 - e−D/D0)n is plotted, where D0 = 2.5 J/cm2, and
n is varied. Error bars seem large at higher doses, but this is just a result of the
semilogarithmic axis.
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5.3 Cell death following HAL-PDT with fractionated light
delivery
As Figure 5.11 shows, fractionating the light delivery as defined on p. 33 did not affect
the cells in the manner foreseen. Fractionating the dose giving 50 percent survival after
1 h gave no different results than continuous delivery. But splitting the dose in two,
separated by a dark interval of 5 minutes, more than halved the surviving fraction. The
trend is confirmed by both methods of detection — flow cytometry using Ax and PI,
and the MTT assay, which measures mitochondrial activity. Intermediate results from
absorption measurements are included in Appendix A.2, Figure A.2.
It also seems that the split dose method gives a higher level of apoptosis than the
other means of light delivery (Figure 5.11b). The level is not high compared to the
necrotic level, but it is the double of what is achieved by giving continuous or fractionated
light delivery.
The viable fraction is measured relative to untreated control samples in the MTT
assay while they are absolute values when measured by flow cytometry. The detection
is also based on two very different mechanisms — mitochondrial activity in the MTT
assay and lack of fluorescence in the flow cytometer. The measured values are therefore
not expected to be identical. But when the trend is repeated in the two different types
of experiments, it should give a good impression of the situation after HAL-PDT on the
AY-27 cells both 1 hour and 24 hours after treatment.
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Figure 5.11: (a): Viable fraction 1 h and 24 h after HAL-PDT (10 µM, 3.5 h, LD50),
measured by flow cytometry using Ax/PI. In addition, MTT viability results 1 h and
24 h after the same treatment are shown. (b): Apoptotic and necrotic fraction 1 h and
24 h after HAL-PDT (10 µM, 3.5 h, LD50), measured by flow cytometry using Ax/PI.
The bars represent mean values of 3 independent and identical experiments, each done in
duplicates. Error bars give the mean value ± standard deviation. Notice that of esthetic
reasons the post PDT times have been assigned different colors in the two figures.

Chapter6
Discussion
6.1 Cell survival after red light HAL-PDT
In this study we were especially interested in the modes of cell death after HAL-PDT
in AY-27 cells. As secondary apoptotic cells will be difficult to segregate from necrotic
cells, we based the dose-response curves on measurements done approximately 1 h after
treatment. Because the flipping of phosphatidylserine from the inner to the outer lipid
layer occurs early in apoptosis [43], we should be able to detect apoptotic cells with the
Ax/PI method.
As will be discussed later, there may be some problems with the specificity of the
Ax/PI method for detection of apoptosis. Still, the surviving cells, excluding both dyes,
should be adequately represented also by this method. This can be seen in the untreated
samples where the measured fraction of viable cells is larger than 90 percent, which is
a reasonable estimate of the amount of viable cells in a population. The survival curve
obtained in this study can thus be compared to survival curves obtained also by other
methods, such as the MTT assay.
6.1.1 Comparing experimental survival curves
When comparing survival curves, it is important to remember that wavelength and ir-
radiance influence the survival of the cells. As the absorption spectrum of PpIX in
Figure 2.4 shows, the absorption is three times as efficient at 435 nm (blue light) com-
pared to 630 nm (red light), increasing the probability per second for exciting a PpIX
molecule into a triplet state which can react with oxygen. This probability per second
will also increase by increasing the light irradiance.
In the project work performed last semester [47], a survival curve for the AY-27
cells 24 h post HAL-PDT was established using the MTT assay. The experiments were
performed using the same light source and the same photosensitizer concentration, but
with different irradiances. The survival curve from the former experiments, using an
irradiance of 36 mW/cm2, was comparable to HAL-PDT (10 µM, 3.5 h) on AY-27 cells
using blue light (435 nm, 12.9 mW/cm2) [48]. These survival curves decrease rapidly,
without an initial shoulder region (or a much smaller shoulder), giving an appearance of
a single hit, single target system. If the survival curve shown in Figure A.1, Appendix
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A.1, is compared to results from blue light experiments performed by Linda Helander
[48], it is evident that equal dose using red or blue light gives equal treatment outcome
in vitro, if a correction for absorption is included in the results. The LD50 dose was
1.15 J/cm2 after 24 hours for red light, three times the value for blue light experiments:
0.38 J/cm2. This corresponds to the absorption of light being three times as efficiant at
435 nm than at 630 nm.
Figure 5.8a illustrates that decreasing the red light irradiance from 36 mW/cm2 to
20 mW/cm2 produces survival curves which tell another story — not simply a single hit,
single target situation. Ionizing radiation used in vitro can produce similarily shaped
survival curves, and the shoulder region is explained both by sublethal damage repair
and the need for several “hits” to produce lethal damage [38]. Enzymatic repair of single
or double stranded DNA breaks is established as able to produce an initial shoulder,
and fractionating or splitting the radiation dose will cause the shoulder region to repeat,
thus causing the overall survival to increase.
Figure 5.11a shows a decrease in cell survival when the LD50 (1h post PDT) is split
in two separate fractions — the opposite of what would be expected if sublethal damage
repair was active in the dark period. The initial shoulder of the survival curve combined
with the decrease in survival in split-dose experiments give indications that sublethal
damage repair is not an important mechanism in photodynamic treatment as performed
in this study. The shoulder would then be a result of the fact that several targets in a
cell need to be hit to produce sufficient damage for cell death.
6.1.2 Comparison to theoretical survival curves
As the dose increases, the survival curve from the single hit, multi target model (Eq 2.2)
approaches a single exponential. This exponential will of course decrease towards zero at
high doses. The number of targets that need inactivation, denoted n, can be estimated
in a semilogarithmic plot by extending the linear part of the survival curve to find the
intersection with the y-axis, after fitting the single hit, multi target survival curve to
the experimental data.
S = 1− (1− e−D/D0)n
= 1− (1− ne−D/D0 + n
2
e−2D/D0 + ...) Large D−−−−−→ ne−D/D0 (6.1)
As seen in Figure 5.10, the survival curve obtained in this study resembles single hit,
multi target survival curves up to a dose of 18 J/cm2, where the measured survival, as
shown in Figure 5.8a, reaches a constant level of 2-3 percent. This level does probably
not represent a true fraction of the population, which would mean that 3 percent of the
cells are resistant to photodynamic therapy. More specifically, they are able to survive
doses up to 36 J/cm2. Although some cells may be more resistant, a survival of 3 percent
at 36 J/cm2 is much larger than the 0.8 percent value at 36 J/cm2 found by the MTT
assay last semester, Appendix A.1, Figure A.1b.
One explanation of the difference in survival between the two methods, could be the
combination of samples consisting mostly of cell fragments and the threshold of detection
in the flow cytometer. Fragments giving an FSC signal under a certain value will not
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be regarded as cells, and are not counted. This will lead to an overrepresentation of
viable cells in the measurement, as the very few living cells are always counted, while
the vast majority of the necrotic cells will go unnoticed. Based on the assumption that
the survival curve should approach zero at high doses, the fitted curve in Figure 5.10
did not use data corresponding to doses over 12 J/cm2.
It is important to remember that the results from curve fitting only present one
small version of the truth. The single hit, multi target model does not differentiate
between apoptotic and necrotic cell death, or between apoptotic and necrotic targets. It
estimates the number of targets of any kind that need inactivation before the cell dies.
How the curve is fitted to the experimental data is also important. Is the shoulder or
the slope more important?
In Figure 5.10, a good fit to the slope was stressed. If all points are considered
equally and a nonlinear least squares fit is performed, the estimate of the number of
targets and the shoulder width is changed to approximately n = 10 and D0 = 2 J/cm2.
The curve and experimental data points are shown in Figure 6.1.
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Figure 6.1: Alternative surivival curve parameters used to fit a single hit, multi target
curve to survival data from flow cytometry 1 hour after red light HAL-PDT. Mean
values are given ± standard deviation. Error bars seem large at higher doses, but this
is just a result of the semilogarithmic axis.
This may look like a good fit, but if the parameter values are given with 95% con-
fidence intervals as in Table 6.1, the impression may change. Still, the quasithreshold
value is similar to what we obtained with n = 6 and D0 = 2.5 J/cm2, demonstrat-
ing that one shoulder width can be obtained by different combination of survival curve
52 Chapter 6 Discussion
parameters.
The single hit, multi target equation has been used with experimental data from
ALA-PDT on WiDr cells [41]. Their estimate of the number of targets to be inactivated
before a cell is killed at 37 ◦C was n = 11 ± 2. Although this value is similar to the
value in Table 6.1, the cell lines are different, and one cannot simply assume that the
same number of lipid or protein inactivations will lead to cell death in both of them.
Table 6.1: Alternative survival curve parameters
Parameters: D0 [J/cm2] n Dp [J/cm2]
Estimated values: 1.89 (1.14, 2.64) 10.41 (0, 21) 4.43
Used in Figure 6.1: 2 10 4.6
We can conclude that the single hit, multi target model is not a perfect match for
our data. But if we were to test different treatment conditions (such as irradiance,
temperature or others) over a range of doses it would be convenient to use the model
for calculating parameters which again could be used in comparing different outcomes.
An example could be different shoulder widths, which could indicate different ability to
accumulate sublethal damage under the different conditions.
6.2 The modes of cell death after HAL-PDT
As PpIX is formed in the mitochondria of eukaryotic cells, it seems reasonable that
HAL-PDT should lead to apoptosis through the activation of the mitochondria mediated
pathway, discussed on p. 10. Our results from flow cytometry using Annexin V Fluos
and propidium iodide does not support this theory, but indicate that necrosis is the most
important way of cell death following HAL-PDT. This could mean that mitochondria
is not the primary targets in our experiments, which leaves the plasma membrane as
a possible replacement. If the oxidative damages to lipids and proteins in the plasma
membrane dominates the lethal damages in a cell, necrosis will follow. Support can be
found at several levels:
6.2.1 Indications of necrosis as dominant mode of cell death
PpIX localization:
Even though PpIX is formed in mitochondria, it rapidly diffuses to other intracellular
membrane sites such as lysosomes and the plasma membrane [49]. Fluorescence mi-
croscopy studies of AY-27 cells 3 h and 4 h after incubation with HAL (1 µM) clearly
shows accumulation of the lipophilic sensitizer in the plasma membrane [35]. In this
study an incubation time of 3.5 h is used, which based on these former results should
lead to a highly sensitised plasma membrane. Sufficient oxidative damages to molecules
in the plasma membrane (e.g. lipid peroxidation) will induce necrosis by loss of plasma
membrane integrity [18].
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Altered adhesive properties:
Cell adhesion proteins, such as integrins and cadherins are integrated in the plasma
membrane. Since singlet oxygen acts in the immediate vicinity of its formation, these
proteins may be damaged if the photosensitizer is present in the lipid bilayer. The adhe-
sive properties of WiDr and D54Mg cells after ALA-PDT have been studied [50], and it
was found that direct effect on the plasma membrane influenced the adhesive properties
of these cell lines. Even sublethal damages influenced their adhesive properties, making
them more resistant to trypsination.
Although we have not studied the adhesive properties of the AY-27 cells by any
sophisticated method here, we have experienced that there is a large difference in their
resistance to detachment by Accutase before and after HAL-PDT. This suggests that
oxidative damages to proteins in the cell membrane may be an important effect in the
AY-27 cells after HAL-PDT (3.5 h, 10 µM, 630 nm).
Indications of an early increase in cell size:
Although one should be careful in interpreting the forward scattered (FSC) light detected
in flow cytometry as a clear measure of cell size, the average FSC signal as a function
of PDT dose, shown in Figure 5.8b, seem to support that necrosis is the dominant way
of cell death following HAL-PDT with our conditions.
Untreated samples show a simple gaussian distribution, averaging at a lower value
than samples which are given low PDT doses. At these low doses, Figure 5.8a shows
little cell death, which means that PI has not yet penetrated the cell membrane to a
large extent. Increase in cell size and an intact cell membrane are features characteristic
of early necrosis or oncosis, where the cell swells — the opposite of apoptotic cells which
will shrink. The increase in FSC signal could then reflect a dominant early necrotic
population. As the dose passes 15 J/cm2, the average FSC signal ceases to decrease,
having reached a level corresponding to near total extinction of the cell population.
Observations in the confocal microscope confirmes that such high doses will lead to
“pulverization” of the cells, already 1 h after treatment.
The influence of an apoptotic window:
The dose range where the damage is too serious to allow repair of the cell, but not severe
enough to endanger the cellular ion homeostasis, can be referred to as the apoptotic
window. This window is influenced by the treatment protocol through parameters such
as incubation time, concentration of photosensitizer and the irradiation regime [23].
In this study we have used the precursor concentration shown to give maximal PpIX
concentration in the cells after 3.5 h incubation, as found by Odrun Arna Gederaas
and Linda Helander at the Department of Cancer Research and Molecular Medicine at
NTNU, which simplifies comparison of the results.
If we had used another treatment protocol, giving a lower concentration of photo-
sensitizer or an even lower light irradiance, the level of treatment induced apoptosis
could increase, as we then might enter into the range of the apoptotic window. Others
have demonstrated that it is possible to induce apoptosis in the AY-27 cell line with
hypericin-PDT, but it is highly dependent on the concentration of the photosensitizer
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and the time of observation. At low concentrations of the photosensitizer, a dose of 1.8
J/cm2 (2 mW/cm2, 595 nm) prevalently induced apoptosis, while the same dose given
after incubation of slightly higher concentrations of hypericin prevalently induced necro-
sis [51]. From our studies, it seems that giving 10 µM of HAL 3.5 h before irradiation
with red light of 20 mW/cm2 is not the best way of inducing apoptosis in the AY-27
cell line.
6.3 A discussion of the methods and possible impacts on
the results
6.3.1 Are we missing the apoptotic cells?
The indications of necrosis as the dominant mode of cell death after red light HAL-PDT
are many, as our experiments fail to give us the evidence of an apoptotic level higher
than 10 percent after treatment. Still, if Figure 5.11 is studied, some questions about the
Ax/PI method arise. Among others, the discrepancy between the measured apoptotic
level and the mitochondrial activity 1 h and 24 h after treatment should be discussed.
First, take a look at Figure 5.11b. There is approximately a 25 percent difference
between the necrotic level 1 hour and 24 hours after treatment. As necrosis arises shortly
after treatment, one would not expect such a large difference. The increase could be
explained if the level of apoptotis had decreased correspondingly, because cells which
are apoptotic after 1 hour are expected to reach a necrotic stage after 24 h. But this is
not seen here, as the apoptotic level is nearly unchanged. This may indicate that the
level of apoptosis measured 1 h after treatment is too low.
Secondly, look at Figure 5.11a. The MTT assay measures mitochondrial (metabolic)
activity, and according to Plaetzer et al. [23], the temporal dynamics of the mitochon-
drial activity will reflect the apoptotic fraction of cells after AlPcS4-PDT when measured
3 and 24 hours after treatment. Our MTT results show a dramatic change in metabolic
activity in the cell population 1 hour and 24 hours after treatment. 1 hour after treat-
ment, about 35 percent of the cell population show the ability to convert MTT to
formazan after continuous delivery of the LD501 dose. 24 hours after treatment, only 10
percent are able to do the same. According to Plaetzer et.al, the difference between the
two measurements represents the apoptotic fraction of the population. If this is true in
our system also, we may have greatly underestimated the apoptotic fraction by using
the Ax/PI method.
6.3.2 Timing
In our experiments, measurements are done by definition 1 hour and 24 hours after
treatment. These post-PDT times were chosen as the most important, as it is impossible
to investigate all points in time after treatment. The true time of measurement is not
exactly as defined though, because the measurements are not done instantaneously. This
is illustrated in Figure 4.6. After treatment, the samples are left undisturbed for one
hour (or 24 h) in normal cultivation medium. If they are to be studied in the flow
cytometer, they need detachment (20 min), centrifugation (3 min) and incubation with
1Defined 1 hour after treatment
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Ax/PI (15 min). Including working time, the time from treatment to measurement
approaches 2 h.
If the cells are to be studied by the MTT assay, they are also left undisturbed for one
hour (or 24 h) and incubated with the MTT solution (1 h) before the formazan is solved
in isopropanol. At that stage though, the cells will die, and the time spent after addition
of isopropanol is not as important. It is the amount of formazan produced before the
addition of isopropanol that gives information of how and when the cells die. Both
methods then lead to a time of measurement of 2 hours after treatment, where 1 hour is
spent undisturbed. It is unclear exactly how treatment post-PDT, such as detachment
or incubation with the MTT solution, influences the normal post-PDT processes in the
cell. But if processes such as cell repair continue during this treatment, the true time of
measurement is not 1 h post-PDT, but 1.5 - 2 h (and ≈ 25 h) post-PDT .
The execution of apoptosis may take several hours [52], and although PS exposure
happens at an early stage [43], we may have missed the event by measuring earlier than
2 h after treatment. However, this reasoning is contradicted by the results from the
pilot studies with Annexin V Fluos and propidium iodide shown in Figure 5.2, which
did not reveal any large differences in the apoptotic level 1 h and 4 h after PDT. Still,
these doses were small, ranging only from 0 to 2.4 J/cm2. Also, at the largest dose, the
fraction of viable cells was as high as 75 percent 4 h after treatment.
HAL-PDT has been found to effectively induce apoptosis in human leukemia cells
(5 µM, 4 h, 8 mW/cm2, 450 nm, Furre et al.) [53], where cellular shrinkage and pe-
ripheral chromatin condensation were displayed from 4 h after treatment. 20 h after
a dose of 160 mJ/cm2, more than 80 percent of the population was characterized as
apoptotic, as found from fluorescence microscopy images. Furre et al. suggest that
mitochondria initiated — and perhaps also cell surface death receptor induced, path-
ways of caspase activating cascades are not involved in the induction of apoptosis by
HAL-PDT. The apoptosis inducing factor (AIF) which is released from mitochondria
and translocated to the nucleus was investigated in their study and was suggested to
play a central role in a caspase (and cytochrome C) independent induction of apoptosis.
As the translocation from the mitochondria to the nucleus via the cytosol takes time,
the highest apoptotic level was found 20 hours after treatment, with approximately 55
percent reached after 6 hours. This slow progression is consistent with the results of
another study by Wyld et al. [54], where the apoptotic level after ALA-PDT (1 mM,
4 h, 350-450 nm, 86.5 mW/cm2, LD50) on human bladder carcinoma cells was largest
after 8 hours, reaching a level of 55 percent.
6.3.3 A reconsideration of the Ax/PI assay
There are some problems regarding the use of the Ax/PI assay to detect apoptosis,
especially when used with adherent cells. According to Lecoeur et al. [21], the Ax/PI
assay does not discriminate between apoptosis and oncosis. In addition, the detachment
process can cause mechanical damages to cells which can lead to false positives.
The first problem should cause an overestimation of the apoptotic population, but
that does not seem to be a problem here, as our measurements of the apoptotic fraction
is rather low. The second problem should lead to an overestimation of the necrotic
population. This could be a problem, if we by detaching the cells make them permeable
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to the fluorochromes. Still, this should be evident also in control samples, and the results
from flow cytometry does not show a high necrotic or apoptotic level in the untreated
samples. In fact, the control samples come out as 95% viable, indicating that most of
the cells remain viable also after the detachment process. If this is not the case, the
fluorochromes are extremely inefficient in binding to their substrates.
It is difficult to conclude whether or not the lack of apoptosis measured by the
Ax/PI assay reflects lack of apoptosis in the cell population after red light HAL-PDT.
The measurement technique is never perfect, and there is no general kinetic model of
how cells react to photodynamic therapy. As much is unknown about the response of the
AY-27 cells to PDT, and as the time of measurement post PDT seems to be important
(discussed on p. 54), the cell population should be followed over time, instead of just
the two time points we were able to study here.
Including other markers of apoptosis in future experiments, such as disruption of the
mitochondrial transmembrane potential (∆Ψm), would be useful. The collapse of the
transmembrane potential during apoptosis can be studied by flow cytometry or confocal
microscopy by using the ∆Ψm sensitive dye JC-12 [53]. Reliable conclusions about the
amount and kinetics of induction of apoptosis in the AY-27 cell line after HAL-PDT
should be supported by several methods, not only results from one apoptotic marker,
such as the display of phosphatidylserine.
6.3.4 Conditions before and during treatment influence the outcome
of PDT
After incubation with HAL, the cells are washed in PBS. They stay in PBS before and
during light delivery, but because of the experimental protocol in the fractionation and
split-dose experiments, the time spent in the incubator with a 5% CO2 content varies
between 5 and 30 minutes before irradiation. As Figure 6.2 shows, this may influence
the outcome of treatment at long irradiation times, such as those used to obtain a dose
of 5.4 J/cm2 in a split-dose experiment. Results from earlier experiments show that the
incubator time is not as important at lower doses.
Results from the fractionation and split-dose experiments are found in Figure 5.11.
One hour after treatment the survival is lower with a factor of two in the split-dose
samples compared to those where continuous or fractionated irradiation is given. As
this result was unexpected, it was decided to test a hypothesis that the time in the
incubator before treatment could influence the treatment outcome. Figure 6.2 shows
the results of a split dose experiment where 5.4 J/cm2 has been delivered in two equal
fractions to all samples, but the time spent in the incubator before treatment is different.
One hour after treatment, 50 percent of the cells which were incubated 15 or 30 minutes
before treatment were viable compared to only 25 percent of the cells with the shortest
incubation time.
In the fractionation experiments, the split-dose samples were treated first, after 5
minutes in the incubator. If the effect seen in Figure 6.2 is included, it leads to the
conclusion that the treatment outcome is not changed between the three modes of light
delivery tested in this study. The difference in survival must have its origin somewhere
else.
2A J-aggregate forming lipophilic cation [55]
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After the cells have been washed and left in PBS, they will experience the pH and gas
concentrations as given by the buffer solution. PBS, phosphate buffered saline, contains
phosphate compounds instead of carbonate compounds to avoid pH changes when work-
ing in atmospheric conditions, and pH changes should thus not be a problem. Because
the concentration of CO2 in the incubator and the atmosphere (air) is respectively 5%
and 0.03% [56], disturbances in the amount of oxygen and carbon dioxide present in the
PBS could influence the treatment outcome, as oxygen is a limiting factor in the PDT
treatment and CO2 is a singlet oxygen quencher [57]. In addition, the cells with the
shortest stay in the incubator may still be recovering from mechanical stress following
the washing procedure, and could be more sensitive to oxidative damages than normal.
Although these are only speculations, the fact remains that there is a difference in
the outcome of PDT between samples incubated for different times before treatment,
where a stay of only 5 minutes in the incubator seem to reduce the cells ability to survive
compared to incubation times of 15 or 30 minutes.
6.4 The effects of fractionated irradiation
Contrary to what we expected, we found no difference in PDT efficacy between fraction-
ated and continuous light delivery. The treatment regime consisting of light/dark/light
intervals of 45 s/60 s/45 s until the LD50 dose was reached, was inspired by a study
performed by Oberdanner et al. [46], where a decrease in PDT efficacy was found when
the light delivery was fractionated in this manner. They found that PDT doses leading
to 10 percent mitochondrial activity (measured by the MTT assay) 24 h after treatment
with continuous light delivery, lead to 20 percent survival when fractionated irradiation
was used. The study was perfomed using the lipophilic, singlet oxygen generating photo-
sensitizer hypericin on the adherent cell line A431, which resembles the situation in our
system. It was suggested that fractionated therapy in vitro is influenced by the recycling
of GSH by glutathione reductase during the dark intervals. GSH is a ROS quencher and
if recycled it could explain the increase in survival levels when fractionated irradiation
was used compared to survival after treatment with continuous irradiation.
The increase in survival was not seen in our study, indicating that the recycling of
GSH is not as efficient in our system. Maybe the glutathione reductase is itself damaged
by ROS? Still, there may be an underlying effect of GSH, which could be determined by
adding BCNU, an inhibitor of glutathione reductase, to the cultivation medium before
irradiation. If the survival then decreases compared to samples without BCNU, the effect
of GSH recycling is demonstrated. Without having performed such an experiment, one
could still suggest that factors that should increase PDT efficacy, such as regeneration
of PpIX and reoxygenation in the dark intervals, were counteracted by a mechanism
such as GSH recycling — leading to equal survival with continuous and fractionated
light delivery in our experiments. On the other hand, depletion of oxygen is not likely
to be a problem in vitro, as there is continuous gas exchange between the supernatant
and the outside air.
Sublethal damage repair could also influence the outcome of fractionated therapy,
as repair mechanisms could be active in the dark intervals. Still, repair is not assumed
to happen in dark intervals of only 60 s, and should not be influencing the results of the
fractionated regime to a large extent.
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It seems from our results that a dark period of 5 minutes does not have any significant
influence of repair processes either, as the survival was equal between samples recieving
fractionated and split-dose PDT.
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Figure 6.2: Results of a red light HAL-PDT (10 µM, 3.5 h) split-dose experiment
(135 s light, 300 s dark, 135 s light). The samples were kept in their regular incubator
with 5% CO2 5, 15 or 30 minutes before treatment, and the viability measured 1 hour
and 24 hours after treatment. MTT results for (1h, 15 min) is missing due to lack
of data at this point. Notice that of esthetic reasons the post PDT times have been
assigned different colors in the two figures.
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Fractionated therapy in vivo
In vivo, fractionation has been found to both increase [58] and decrease PDT efficacy [59].
By measuring the partial oxygen pressure, pO2, effective reoxygenation schemes using
ALA-PDT has been shown to require dark intervals of 150 s [60], while others again
report that several hours is needed [61]. As the results differ to a large extent between
the investigators, timing of the dark interval(s) is probably influential for the outcome
and further optimization is needed. By studying the effects of fractionation in vitro,
the direct cellular mechanisms determining the treatment outcome can be revealed.
These results cannot be translated directly all in vivo situations, as the effect of tissue
oxygenation may be more influential for the PDT efficacy. But for well oxygenated
tumors, in vitro results may give important information about response to PDT.
6.5 Future work
If someone is to continue the red light PDT studies on the AY-27 cell line, some changes
in the protocols could be recommended, as well as some additional experiments. One
semester was not enough to carry out all the ideas that came up when the experiments
were performed. As all the final experiments had to be comparable to each other, the
protocols could not be changed during the late stages of the work. Some suggestions to
further investigations are listed here:
1. Too much PpIX in the cells plasma membranes may contribute to the high level
of necrosis found in these experiments. There is a chance that by using regular
cultivation medium instead of PBS while washing the cells before irradiation, some
of the PpIX in the plasma membrane will be extracted. This could increase the
probability of inducing apoptosis, as there would be less PpIX molecules incor-
porated in the plasma membrane, and therefore a lower probability of inducing
direct cell membrane rupture.
2. The fractionation experiments should be repeated using lower doses — preferably
a range of doses should be examined, making an interesting comparison to the
continuous dose-response curves. Changes in shoulder width is one of the phe-
nomena which could provide us with more information about the effects of PDT
on the AY-27 cells, and about accumulation of sublethal damages.
3. Five minutes may be too short time for any repair processes in the cell to function
properly, and longer dark intervals should be tested to look for the existence of an
active sublethal damage repair in the AY-27 cell line after red light HAL-PDT.
4. Figure 5.8b indicates an early increase in cell size after HAL-PDT. It may be
worthwhile to examine the response of the forward scattered signal in the flow cy-
tometer by performing some osmosis experiments with the AY-27 cells to validate
the understanding of the changes in FSC signal as changes in cell size.
Chapter7
Conclusions
• HAL-PDT with our treatment conditions, 10 µM, 3.5 h, using red light of 630 nm
and an irradiance of 20 mW/cm2, induces necrosis as the dominant mode of cell
death in the AY-27 cancer cell line.
• The LD50 dose one hour after treatment is 5.4 J/cm2. 24 hours after treatment
this is equivalent to a LD80 dose.
• No altered effect was detected between treatment with fractionated and continuous
light delivery.
• The survival after split dose treatment seemed to depend on conditions before irra-
diation, but seems otherwise to give the same amount of cell death as fractionated
or continous light delivery.
• Confocal microscopy examination of several samples, such as in a HAL-PDT dose-
response experiment, is time consuming. Analysis of the results is even more time
consuming, and I would therefore not recommend the use of confocal microscopy
in quantitative studies of cell death after photodynamic therapy. It is however a
powerful tool for studies of fluorescence localization and photobleaching, and thus
well suited for qualitative studies of mechanisms activated after PDT .
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AppendixA
Miscellaneous information
A.1 The survival of AY-27 cells after HAL-PDT with dif-
ferent light irradiance
In the biophysics specialization project of fall 2008 [47], AY-27 cells were given HAL-
PDT using the same light source as this semester, but with different irradiance. In the
former study, an irradiance of 36 mW/cm2 was used, while we used 20 mW/cm2 in this
year’s studies. The survival curve is reproduced here for comparison with the results
obtained in this study.
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Figure A.1: The surviving fraction of AY-27 cells 24 hours after red light (630 nm,
36 mW/cm2) HAL-PDT (3.5 h, 10 µM) measured by the MTT assay.
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A.2 Typical MTT results from fractionation experiments
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Figure A.2: Typical results from the spectrophotometric absorption measurements of
the cell produced formazan dissolved in isopropanol 24 hours after HAL-PDT treatment.
The absorption value at 595 nm is used to create bar charts for MTT results such as
in Figure 5.11a. An overview of sample treatment is found in Table A.1. The high
absorption in the treated samples around 400 nm may be due to PpIX present in the
solution.
Table A.1: An overview of sample treatment during the MTT version of the fractiona-
tion experiments, where mitochondrial activity was measured 24 hours after HAL-PDT.
(Samples 1-12 is used in flow cytometry studies 1 hour and 24 hours after treatment)
Sample HAL Irradiation Light[s]/Dark[s]/Light[s] Dilution
13 + Split 135/300/135 1:1
14 + Split 135/300/135 1:1
15 + Frac (45/60/45)x3 1:1
16 + Frac (45/60/45)x3 1:1
17 + Cont 270/0/0 1:1
18 + Cont 270/0/0 1:1
19 - Control 0/0/0 1:10
20 - Control 0/0/0 1:10
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A.3 Contents of HEPES buffer
Table A.2: Contents of the HEPES buffer used in studies with the fluorochromes Ax
and PI
Compound [g/l] in dH2O
Hepes (Sigma) 2.38
NaOH (Merck) 0.368
CaCl2 (Merck) 0.550
NaCl 8.18
A.4 Settings of the flow cytometer
Table A.3: Settings of detectors and amplifiers in the flow cytometer when used with
the fluorochromes Ax and PI
Param Detector Voltage AmpGain FineGain Laser
P1 (FSC) FSC-H 8 Off 1
P2 (SSC) SSC-H 899 8 Off 1
P3 (Ax) FL1-H 500 8 Off 1
P4 FL2-H 391 8 Off 1
P5 FL4-H 693 8 Off 2
P6 FL5-H 501 8 Off 2
P7 FL3-H 999 8 Off 1
P8 (PI) FL6-H 800 8 Off 1
Threshold FSC: 54
Table A.4: Compensation made when using the fluorochromes Ax/PI.
Detector Subtracts [%] Of detector
FL1 (Ax) 1.6 FL6 (PI)
FL6 (PI) 4.0 FL1 (Ax)
